LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 18, 2018 at 12:42 AM.

  1. #1 cafead, Oct 18, 2018 at 12:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,044
    Likes Received:
    3
    via LNC Therapeutics announced on 10/15/18 that it has signed an exclusive license agreement with Cornell University (Ithaca, NY, USA) for its Christensenella patent family.

    article source
     
    Quote

Reply to Thread